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Abstract
Background: Pheochromocytomas are rare catecholamine-producing neuroendocrine tumors. Hypertension secondary
to pheochromocytoma is often paroxysmal, and patients occasionally present with sudden attacks of alternating
hypertension and hypotension. Spontaneous, extensive necrosis within the tumor that is associated with catecholamine
crisis is an infrequent complication of adrenal pheochromocytoma, but its pathogenesis remains unclear.
Case presentation: A 69-year-old Japanese man developed acute-onset episodic headaches, palpitations, and chest
pains. During the episodes, both marked fluctuations in blood pressure (ranging from 40/25 to 300/160 mmHg) and high
plasma levels of catecholamines were found simultaneously. Radiological findings indicated a 4-cm left adrenal
pheochromocytoma. These episodic symptoms disappeared within 2 weeks with normalization of plasma catecholamine
levels. Two months later, the patient underwent adrenalectomy. Microscopic examinations revealed pheocromocytoma
with a large central area of coagulative necrosis. The necrotic material was immunohistochemically positive for
chromogranin A. Granulation tissue was adjacent to the necrotic area, accompanied by numerous hemosiderin-laden
macrophages and histiocytes with vascular proliferation. Viable tumor cells, detected along the periphery of the tumor,
demonstrated pyknosis, and the Ki-67 labeling index was 2 % in the hot spot. No embolus or thrombus formation was
found in the resected specimen harboring the whole tumor. The Pheochromocytoma of the Adrenal gland Scaled Score
was 2 out of 20. The patient’s postoperative course was unremarkable for > 7 years.
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Conclusions: Presumed causal factors for the extensive necrosis of adrenal pheochromocytoma in previously reported
cases include hemorrhage into the tumor, hypotension induced by a phentolamine administration, embolic infarction,
high intracapsular pressure due to malignant growth of the tumor, and catecholamine-induced vasoconstriction. In the
present case, histopathological and clinical findings suggest that under conditions of chronic ischemia due to
catecholamine-induced vasoconstriction, an acute infarction occurred after sudden attacks of alternating hypertension and
hypotension. Over the subsequent 2 weeks, repetitive massive release of catecholamines from the infarcts into circulation
likely accelerated infarction progression by causing repeated attacks of alternating hypertension and hypotension and
resulted in the large necrosis. This case highlights the need for physicians to consider acute spontaneous tumor infarction
accompanying episodic catecholamine crisis as a rare but severe complication of pheochromocytoma.
Keywords: Pheochromocytoma, Hypertension, Hypotension, Immunohistochemistry, Adrenalectomy, Coagulative necrosis,
Chest pain, Metaiodobenzylguanidine scintigraphy
Background
Pheochromocytomas are rare catecholamine-producing
neuroendocrine tumors that arise from chromaffin cells
of the adrenal medulla or extra-adrenal paraganglia [1].
The clinical presentation of pheochromocytoma, which
is usually due to the direct actions of secreted catechol-
amines, is highly variable. Typical clinical presentation
includes episodic headaches, palpitations, and hyperten-
sion. Hypertension is often paroxysmal, and patients oc-
casionally present with sudden attacks of alternating
hypertension and hypotension [2–4].
Spontaneous, extensive necrosis within the tumor that
is associated with acute and severe clinical manifesta-
tions of massive catecholamine release, including acute
abdomen, chest pain, or even shock, is an infrequent
complication of adrenal pheochromocytoma [5–13].
However, the mechanisms underlying the development
of such extensive necrosis remain unclear.
Here, we report a case of a patient who exhibited a large
coagulative necrosis of an adrenal pheochromocytoma as-
sociated with acute attacks of alternating hypertension
and hypotension, on which a detailed histopathological
analysis was performed.
Case presentation
A 69-year-old Japanese man was admitted to our hos-
pital in July 2009 because of 1 week of episodic head-
aches, palpitations, and chest pains. He had a family
history of type 2 diabetes mellitus (T2DM) in his
mother. The patient drank 360 mL/day of sake. He had
a smoking history of one pack of cigarettes/day from 20
to 60 years old. Our patient was diagnosed with T2DM
at the age of 60 years at our hospital and started treat-
ment with diet therapy (1600 kcal/day). He was started
with the oral antidiabetic drug nateglinide (90 mg/day)
at the age of 63 years, and subsequently had fair gly-
cemic control with a mean glycated hemoglobin
(HbA1c) of 7 % (reference range: 4.6–6.2 %) with no dia-
betic retinopathy. He had never had hypertension and
had normal blood pressure (BP), with a systolic and
diastolic BP of around 120 mmHg and 70 mmHg,
respectively. He showed acute-onset episodic headaches,
palpitations, and chest pains at rest in June 2009, which
lasted for 10 to 20 minutes and occurred several times
per day, and was admitted to our hospital.
On physical examination performed at presentation
with no symptoms, he was 161 cm tall, weighed 55 kg,
and his body temperature and blood pressure were
36.2 °C and 106/58 mmHg, respectively. No thyroid
struma, chest rales, heart murmurs, abdominal tender-
ness or mass, or peripheral edema was detected. An
electrocardiogram showed a normal sinus rhythm, with
a heart rate (HR) of 65 beats/minute and no abnormal
wave form. Chest X-ray showed no abnormalities with a
cardiothoracic ratio of 46 %. Laboratory findings showed
a normal complete blood count, normal liver and renal
functions, normal balance of serum electrolytes, and
high HbA1c value (7.6 %).
On day 2 of admission, our patient again experienced
episodic headache, palpitation, and chest pain. During
the episode, an electrocardiogram showed nonsustained
ventricular tachycardia. His symptoms resolved within
20 minutes after sublingual administration of nitrogly-
cerin (0.3 mg), which was administered as diagnostic
therapy for ischemic heart disease, but it was unclear
whether the drug was responsible for the observed im-
provement. Although an electrocardiogram did not show
significant changes in the ST-T segment, the possibility
of acute coronary syndrome remained because of his
noticeable chest symptoms, and our patient received
cardiac catheterization on the same day. Coronary arteri-
ography showed no significant coronary artery lesion,
and left ventriculography showed normal ventricular
function with a left ventricular ejection fraction of 69 %.
However, during the test, he again experienced episodic
headache, palpitation, and chest pain accompanied by
marked fluctuations of systemic BP (ranging from 40/
25 mmHg to 300/160 mmHg). Catecholamine levels
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(noradrenaline 10.8 ng/mL, reference range: 0.10–0.50 ng/
mL; adrenaline 8.8 ng/mL, reference range: 0–0.10 ng/
mL) in his plasma taken during the attacks of alternating
hypertension and hypotension were high. Neck, chest,
and abdominal computed tomography (CT) performed
following cardiac catheterization showed a 4-cm left
adrenal tumor without any other mass lesion. He was
believed to have possible pheochromocytoma, and
treatment with an alpha 1 adrenergic blocker, oral
doxazosin, (2 mg/day) was begun.
Urinary excretion of catecholamines (noradrenaline
2592 μg/day, reference range: 26–230 μg/day; adrenaline
2032 μg/day, reference range: 1.0–29 μg/day) and meta-
nephrines (normetanephrine 3.5 mg/day, reference
range: 0.10–0.28 mg/day; metanephrine 6.0 mg/day,
reference range: 0.04–0.18 mg/day) in a 24-hour urine
sample collected from days 2 through 3 of admission
were high. An iodine-123 metaiodobenzylguanidine
(MIBG) scan detected no pathological accumulation in
the patient’s whole body, including the region of the left
adrenal gland. Gadolinium-enhanced T1-weighted mag-
netic resonance imaging (MRI) indicated altered inten-
sity in a 4-cm left adrenal tumor, and an area of high
intensity was found along the periphery of the tumor,
which persisted until the delayed phase (Fig. 1a, b).
Taken together, our patient was diagnosed with left
adrenal pheochromocyroma containing a large necrosis.
Our patient no longer experienced episodic headaches,
palpitations, chest pains, or labile BP by day 5 of admis-
sion. Plasma levels of noradrenaline (0.38 ng/mL) and
adrenaline (0.10 ng/mL) measured on the morning of
day 7 were normal. In preparation for adrenal surgery
[1], the dose of doxazosin was titrated to 12 mg/day, and
he was discharged on day 19 after admission.
Our patient underwent laparoscopic left adrenalectomy
in September 2009. The histopathological features of the
tumor were consistent with those of intra-adrenal para-
ganglioma (pheochromocytoma) [14] (Fig. 2). The tumor
had a large area of coagulative necrosis in the center. The
necrotic material was immunohistochemically positive for
cytoplasmic components, such as synaptophysin and tyro-
sine hydroxylase, and was markedly positive for the
neuroendocrine granule component, chromogranin A.
Numerous hemosiderin-laden macrophages and histio-
cytes accompanied by vascular proliferation were detected
in the region around the area of necrosis. The viable areas
located at the periphery of the tumor contained numerous
cells undergoing pyknosis, and the cytoplasm of these
tumor cells was immunohistochemically positive for
synaptophysin, tyrosine hydroxylase, and chromogranin
A. The tumor cell nuclei were positive for SDHB. The
Ki-67 labeling index was 2 % in the hot spot. The
Pheochromocytoma of the Adrenal gland Scaled Score
(PASS) [15] was 2 (two factors, nuclear pleomorphism
and hyperchromasia, were met) out of a maximum
score of 20. No embolus or thrombus formation, ath-
erosclerosis, or vasculitis was found in the resected
specimen harboring the whole tumor.
The patient discontinued oral doxazosin just after sur-
gery and had no recurrent episodic headache, chest
symptoms, or labile BP. His T2DM was treated with
continued oral nateglinide, with a mean HbA1c of 7 %. His
postoperative course during close follow-up for > 7 years
has been uneventful without local or distant recurrence of
pheochromocytoma.
Discussion
An elderly Japanese patient exhibited spontaneous large
necrosis of adrenal pheochromocytoma that manifested
as 2 weeks of episodic headaches, palpitations, chest
pains, and rapid fluctuations of hypertension and
hypotension. Our patient underwent laparoscopic adre-
nalectomy 2 months after the episodes, and a diagnosis
of pheochromocytoma was confirmed by immunohisto-
chemistry. Light microscopic examination revealed a
large coagulative necrosis in the tumor (Fig. 2). This
finding was similar to those of previously reported cases
of adrenal pheochromocytoma with a large central area
of pure necrosis without hemorrhage or tumor rupture
[5–7, 9–11]. In our patient, the necrotic material,
a b
Fig. 1 Magnetic resonance imaging (July 2009). Gadolinium-enhanced T2-weighted magnetic resonance imaging (a, early phase) indicated altered intensity
in a 4-cm left adrenal tumor (arrow), and an area of high intensity was found along the periphery of the tumor, which persisted until the delayed phase (b)
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containing morphologically ghost cells, yielded positive
immunoreactivity for chromogranin A. Granulation tis-
sue was adjacent to the necrotic area, accompanied by
the presence of numerous hemosiderin-laden macro-
phages and histiocytes with vascular proliferation. Viable
tumor cells were detected along the periphery of the
tumor and demonstrated the presence of pyknosis. The
viable tumor cells had a Ki-67 labeling index of 2 %,
which did not necessarily indicate increased tumor prolif-
erative activity. These findings suggest that the pheochro-
mocytoma in our patient exhibited chronic ischemia due
to abnormal vascular flow, and then acute infarction [16]
occurred in the tumor resulting in the extensive necrosis.
Presumed causal factors for the extensive necrosis of ad-
renal pheochromocytoma in previously reported cases in-
clude hemorrhage into the tumor [8, 12, 13], hypotension
induced by a phentolamine administration [5, 9], high
intracapsular pressure due to malignant growth of the
tumor [6], infarction secondary to vascular occlusion by
an embolism [17], shock [10], and catecholamine-induced
vasoconstriction of vessels supplying and/or within the
tumor [7]. In the present case, no embolus or thrombus
formation, atherosclerosis, or vasculitis was found in the
resected specimen harboring the whole tumor. The sud-
den attacks of alternating hypertension and hypotension
(with systolic BP ranging from 40 mmHg to 300 mmHg),
accompanied by episodic headaches, palpitations, and
chest pains, were simultaneously documented with a
catecholamine burst during a cardiac catheter test. These
findings suggest that under the conditions of chronic
ischemia within the tumor due to catecholamine-induced
vasoconstriction, a certain-sized acute infarction occurred,
caused by sudden attacks of alternating hypertension and
hypotension, in our patient. Subsequently, repetitive
massive release of catecholamines from the infarcts into
the circulation probably accelerated the progression of in-
farction by causing repeated attacks of alternating hyper-
tension and hypotension accompanied by headaches,
palpitations, and chest pains and resulted in the extensive
necrosis within his pheochromocytoma.
Many previously reported cases of extensive necrosis
in adrenal pheochromocytoma showed spontaneous
remission of catecholamine crisis even before they
underwent surgical removal of the tumor [5, 6, 12, 13].
In the present case, our patient’s acute-onset episodic
headaches, palpitations, chest pains, and rapid fluctua-
tions of hypertension and hypotension disappeared
within 2 weeks with normalization of plasma catechol-
amine levels. These findings suggest that the large
necrosis of our patient’s adrenal pheochromocytoma
may have been completed over the 2 weeks.
Patients with extensive necrosis of adrenal pheochromo-
cytoma often present with abdominal pain [5, 6, 12, 13, 17].
In the present case, the patient did not present with ab-
dominal pain but exhibited episodic chest pains accompan-




Fig. 2 Histopathological findings of the resected left adrenal gland (September 2009). a Gross appearance of the cut surface of the left adrenal
tumor 3 cm in size showed the inferior surface to be necrotic. b−i Microscopic examination of the left adrenal tumor (b, d−f; hematoxylin and
eosin staining. c, g−i; chromogranin A staining). Nontumoral adrenal gland in the right lower corner, and well-encapsulated tumor in the remainder of
the photograph (b). The tumor had a large area of coagulative necrosis in the center. The necrotic material contained morphologically ghost cells (d, e)
and was immunohistochemically markedly positive for chromogranin A (c, g, h). There were numerous hemosiderin-laden macrophages and histiocytes
accompanied by vascular proliferation in the region adjacent to the area of necrosis (e, h). The viable region along the periphery of the tumor contained
numerous cells undergoing pyknosis (f), and the cytoplasm of the tumor cells was positive for chromogranin A staining (i)
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in the absence of evident cardiac disorder. Although pa-
tients with pheochromocytoma infrequently exhibit cardiac
disorders causing chest pain, such as coronary artery dis-
ease and cardiomyopathy [18], cases of chest pain as an
atypical manifestation of pheochromocytoma in the ab-
sence of a cardiac disorder have also been reported [19, 20].
Thus, although the precise mechanism remains un-
clear, our patient’s chest pain was probably due to
intermittent massive release of catecholamines during
the course of the development of the extensive necro-
sis of pheochromocytoma.
Most previously reported cases of spontaneous large
necrosis of adrenal pheochromocytoma without rupture
were shown to be benign [5, 7–13], but malignant cases
have also occasionally been reported [6]. PASS is a histo-
logical scoring system used in clinical practice to
separate benign from malignant pheochromocytomas by
histomorphological parameters [15]. In this system,
tumors with a PASS of 4 or more of 20 are considered
to have potential for malignant behavior. Our patient ex-
hibited a solitary unilateral adrenal pheochromocytoma
that had a PASS of 2 and experienced no recurrence
during postoperative follow-up for more than 7 years.
Since recurrence of pheochromocytoma may occur even
decades after surgery [21], further careful follow-up was
needed in our patient.
Iodine-MIBG scintigraphy, in combination with ana-
tomical imaging such as CT or MRI, has been used as a
diagnostic tool for detecting chromaffin cell tumors in
patients with biochemically confirmed pheochromocy-
toma [1]. The sensitivity of iodine123-MIBG scintig-
raphy for detecting pheochromocytoma is approximately
90 % [22], and known factors responsible for false-
negative results include extra-adrenal or small adrenal
pheochromocytoma, succinate dehydrogenase subunit B
(SDHB) gene mutations, drug interference, and extensive
necrosis in the tumor [1, 9, 23, 24]. In the present case,
the extensive necrosis in his adrenal pheochromocytoma
was probably responsible for the false-negative result on
iodine123-MIBG scintigraphy.
Conclusions
Histopathological and clinical findings suggest that
under the conditions of chronic ischemia within the
tumor due to catecholamine-induced vasoconstriction,
an acute infarction occurred after sudden attacks of
alternating hypertension and hypotension in our
patient. Over the subsequent 2 weeks, a repeated
massive release of catecholamines from the infarcts
into the circulation probably accelerated the progres-
sion of infarction by causing episodic attacks of alter-
nating hypertension and hypotension, resulting in the
extensive necrosis of adrenal pheochromocytoma. This
case highlights the need for physicians to consider
acute spontaneous tumor infarction accompanying
episodic catecholamine crisis as a rare but severe
complication of pheochromocytoma.
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